SWEDEN - CapMan and Investor Growth Capital invest in Neoventa Medical

Following the investments, CapMan Life Science IV and Investor Growth Capital will each have an approximately 30% stake in Neoventa. The majority of the other shares will be retained by SEB Företagsinvest. The new shareholder structure will together secure a total capital injection of EUR 8m that will finance the next phase of growth for Neoventa with a focus on the US market.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics